Tag Archives: fda

Sagent Pharmaceuticals, Inc. Issues Nationwide Recall

November 19, 2021, Sagent Pharma announces a voluntary nationwide recall of Levetiracetam Injection.  Four lots of Levetiracetam was recalled due to the lack of a sterile product.  Issues pertaining to container closure integrity was brought to attention when found in reserve sample vials.  Sagent Pharmaceuticals did not follow USP suggested guidelines for container closure integrity—distributing…
Read more

ICU Medical, Inc. Amino Acid Injection Recall

Particulate matter was found in an Amino Acid Injection in September.  ICU Medical, Inc. voluntarily recalled one lot of Aminosyn II, 15% of 2,112 units.  This is a Sulfite Free IV solution used in hospitals.  The recall was enforced due to particles such as fibers, hairs and proteinaceous materials.  These particles were found when ICU…
Read more

Greenpark Compounding Pharmacy Ophthalmic Recall

Greenpark Compounding Pharmacy produced and distributed compounded products from Prescription Labs Inc. nationwide.  These products are intended to be sterile and could be life-threatening if used when not sterile. FDA discovered in July/August that the conditions of Greenpark Compounding Pharmacy’s facility could be causing contamination to the compounded drugs they were manufacturing.  On August 18…
Read more

Novavax’s COVID-19 Vaccine

Novavax created the fourth COVID-19 vaccine that could be available in the US this year.  This vaccine is reported to be a two-dose regimen and is highly effective out of all other US vaccines during the clinical trial.  Novavax is seeking FDA approval and authorization while in the third quarter of their testing. Novavax is…
Read more